pro: vedolizumab should be used before anti-tnfs for moderate to severe ibd
Published 9 years ago • 9.5K plays • Length 12:04Download video MP4
Download video MP3
Similar videos
-
10:25
con: anti-tnfs should be used before vedolizumab for moderate to severe ibd
-
21:59
the treatment of moderate to severe ibd with anti-tnf biologics and immunomodulators
-
21:14
when and how to use immunomodulators and biologics in ibd
-
7:06
con: we are not yet ready to use vedolizumab in pediatric ibd
-
8:32
pro: we are ready to use vedolizumab in pediatric ibd
-
21:13
update on vedolizumab in ibd: what have we learned?
-
21:02
should we change how we position biologics for use in crohn’s disease?
-
5:50
vedolizumab safe for inflammatory bowel disease – ibd in the news
-
8:25
vedolizumab as a treatment for crohn’s disease: efficacy and safety
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
45:53
improvements in targeted ibd management: innovative biologics and small molecules
-
21:36
how will future therapeutic pathways change for ulcerative colitis and crohn's disease?
-
12:58
positioning of biologics and new therapeutics for crohn's disease
-
18:23
selection and use of the new and coming therapies for ibd? who? when? how?
-
32:29
keynote speaker: understanding the monitoring and safety of ibd medications and biologics
-
4:30
anti-tnf therapy and remission rates in pediatric crohn's disease - ibd in the news
-
13:19
ibdclub |june 2023| vedolizumab vs. ustekinumab in crohn's disease
-
21:36
keynote: evolution of disease management in ibd
-
23:55
new biologic therapies that target the il-12/23 pathway